EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma

Kevin Y Wu iD, Xingao C Wang, Maude Anderson, Simon D Tran iD

Molecules · 11.05.2024 · 29 (10) · 2263

DOI: 10.3390/molecules29102263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.05.2024. Verfasst von Kevin Y Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada. Hauptthemen laut MEDLINE: Retinoblastoma, Drug Delivery Systems. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The eye’s complex anatomical structures present formidable barriers to effective drug delivery across a range of ocular diseases, from anterior to posterior segment pathologies. Emerging as a promising solution to these challenges, nanotechnology-based platforms—including but not limited to liposomes, dendrimers, and micelles—have shown the potential to revolutionize ophthalmic therapeutics. These nanocarriers enhance drug bioavailability, increase residence time in targeted ocular tissues, and offer precise, localized delivery, minimizing systemic side effects. Focusing on pediatric ophthalmology, particularly on retinoblastoma, this review delves into the recent advancements in functionalized nanosystems for drug delivery. Covering the literature from 2017 to 2023, it comprehensively examines these nanocarriers’ potential impact on transforming the treatment landscape for retinoblastoma. The review highlights the critical role of these platforms in overcoming the unique pediatric eye barriers, thus enhancing treatment efficacy. It underscores the necessity for ongoing research to realize the full clinical potential of these innovative drug delivery systems in pediatric ophthalmology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaDrug Delivery SystemsHumansDrug CarriersChildNanoparticlesMicellesLiposomesDendrimersRetinal NeoplasmsAdministration, OphthalmicNanotechnology

Stichwörter der Autor:innen

drug delivery systems (DDS)nanomedicinenanoparticlesnanosystemsnanotechnologyocular drug deliverypediatric ocular diseaseretinoblastoma

Substanzen

Drug CarriersMicellesLiposomesDendrimers

Autor:innen und Institutionen

  • Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada.
  • Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3T 1J4, Canada.
  • Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC H3A 1G1, Canada.

ORCID-Profile: Kevin Y Wu, Simon D Tran

Zitieren

APA

Wu, K. Y., Wang, X. C., Anderson, M., & Tran, S. D. (2024). Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma. Molecules, 29(10), 2263. https://doi.org/10.3390/molecules29102263

Vancouver

Wu KY, Wang XC, Anderson M, Tran SD. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma. Molecules. 2024;29(10):2263. doi:10.3390/molecules29102263

BibTeX
@article{Wu2024,
  author = {Wu, Kevin Y and Wang, Xingao C and Anderson, Maude and Tran, Simon D},
  title = {Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {10},
  pages = {2263},
  doi = {10.3390/molecules29102263}
}
Kostenlos starten →